Pramipex 0.5mg
Available Dosages
| SKU | 813 |
|---|---|
| Generic For | Miraprex |
| Strength | 0.5mg |
| Active Ingredient | Pramipexole |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.62 | US$ 18.50 | |||
|
|||||
| 60 Tablet/s | US$ 0.53 | US$ 32.0014%US$ 37.00 | |||
|
|||||
| 100 Tablet/s | US$ 0.44 | US$ 44.5028%US$ 61.66 | |||
|
|||||
Pramipex 0.5mg (Pramipexole) – Affordable Miraprex Alternative
Pramipex 0.5mg is used for the treatment of early and late-stage Parkinson’s disease in adults. It provides relief of signs and symptoms of Parkinson’s disease. The symptoms of the disease include tremor (shaking), muscle stiffness, slowness in performing activities of daily living, and mood changes (depression). In the late stage of the condition, Pramipex is generally given in combination with Levodopa.
Pramipex 0.5mg is also a prescription treatment for patients with symptoms of moderate to severe restless legs syndrome. Symptoms of restless legs syndrome include an urge to move the legs, typically accompanied by unpleasant sensations. These symptoms usually start or worsen during periods of inactivity or while resting and can be partially or completely relieved by walking or stretching, if the activity continues. The symptoms only occur in the evening or at night. You may also experience trouble falling asleep, as well as jerky movements in your arms or legs during sleep.
Pramipex 0.5mg contains the active ingredient Pramipexole, which improves the chemical imbalance in the part of the brain affected by Parkinson’s disease or restless legs syndrome.
Pramipex 0.5 Pramipexole o.5mg tablet
Tell your healthcare provider before consuming Pramipex 0.5mg if any of the following apply to you:
- Hypersensitivity to Pramipexole or to any of the medicine’s components.
- Medical history of kidney disorders.
- Medical history of heart problems, such as heart failure and irregular heartbeat.
- Undergoing surgery.
- Allergies to food, medicines, and other substances.
- Sleep diseases such as sleep apnea and narcolepsy.
- Mood, mental or behavioural disorders such as psychosis, confusion, or schizophrenia.
- Vision impairment. You must have regular eye examinations during the treatment.
- Pregnant or intending to become pregnant. You should discuss the benefits and risks of taking Pramipex tablets during pregnancy. Breastfeeding women are advised not to take Pramipexole as it may pass into the breast milk of breastfeeding mothers and harm the nursing baby.
The medicine may cause dizziness. Do not drive or operate machinery while taking Pramipexole, as this medication may require a high degree of mental attention. Drugs that may interact with Pramipex are amantadine (to treat Parkinson’s disease and viral infection), triamterene (for fluid retention in people with heart failure), quinine (to treat malaria), quinidine, (to treat heart rhythm conditions), medicines used to treat high blood pressure and chest pain (such as diltiazem and verapamil), antipsychotic drugs such as phenothiazines, butyrophenones, and metoclopramide.
Pramipex may cause worsening of your psychotic symptoms. Medicines to treat ulcers (cimetidine and ranitidine), and Quinine (to treat malaria). Moreover, avoid alcohol or other sedatives while taking Pramipexole.
Side effects Pramipex 0.5mg
Side effects of the Pramipexole tablet
Like other medicines, Pramipex 0.5mg may cause adverse effects. Seek medical attention in case you develop dizziness, peripheral oedema, anorexia, dry mouth, constipation, hallucinations, nausea, drowsiness, unusual sweating, vomiting, and tiredness.
Some adverse effects of Pramipexole can be serious. Visit the doctor immediately, in case of decreased libido, trouble moving or walking, mood, mental or behaviour changes, muscle spasms, or a sudden drop in blood pressure.
How to use Pramipex 0.5mg?
Usage instruction – Pramipexole tablet
For optimal results, take Pramipex as instructed by your healthcare provider. You may take this medication without regard to food if you become sick to your stomach while taking the medication. The dose of Pramipexole may be increased or decreased gradually to minimise side effects and maximise therapeutic effects. Lower doses are usually prescribed for patients with kidney disorders.
If you have severe kidney disease, Pramipex treatment may not be suitable for you. Do not discontinue the medication without consulting your healthcare provider first. If you need to discontinue medication, your doctor will gradually reduce the dose over time. This helps reduce the risk of symptom worsening. If you have Parkinson’s disease, you should discontinue Pramipex 0.5 mg abruptly. A sudden discontinuity may cause you to develop neuroleptic malignant syndrome, which could be an indication of a major health risk. The symptoms include fever, rigid muscles, loss of muscle movement, confusion, unstable blood pressure, depressed level of consciousness, and tachycardia.
Overdose: Seek medical attention immediately in the case of an overdose of Pramipexole.
Missed Dose: If you have forgotten a dose, take it as soon as you remember and go back to your usual dosing schedule. If the time to take the next dose is near, leave the forgotten dose and take the next scheduled dose. Do not double the dose to compensate for the missed one.
Take the tablet for as long as your doctor recommended.
What is Pramipex 0.5mg used for?
Pramipex 0.5mg contains pramipexole 0.5mg — a mid-range dose in the pramipexole titration schedule for Parkinson's disease (0.5mg three times daily = 1.5mg/day), or as a maintenance dose for restless legs syndrome (0.5mg once nightly). In Parkinson's disease, 0.5mg TID is reached during the second week of dose escalation from 0.125mg → 0.25mg → 0.5mg TID per week. Many patients with mild-moderate Parkinson's disease achieve adequate motor control at doses of 0.5–1mg TID without needing maximum-dose escalation.
How effective is pramipexole 0.5mg TID for Parkinson's disease?
At 1.5mg/day (0.5mg TID), pramipexole begins providing clinically meaningful motor improvement in early Parkinson's disease. Clinical trial evidence shows motor score improvements and a delay in motor complications compared with levodopa when used as monotherapy in early disease. While the full therapeutic effect emerges at 1.5–4.5mg/day, patients with early disease and mild motor disability may maintain adequate control at 1.5mg/day for extended periods before requiring further dose increases or the addition of levodopa. For more information, please talk to your helathcare professional.
How is Pramipex 0.5mg dosed for Parkinson's disease?
Pramipex 0.5mg is taken three times daily (at approximately 8-hour intervals) with food to reduce nausea. From 0.25mg TID (week 2), increase to 0.5mg TID at week 3. If motor control is adequate, maintain at this dose and reassess. If not adequate after 2–4 weeks, continue titrating by 0.25mg TID weekly up to the maximum of 1.5mg TID (4.5mg/day). For RLS: 0.5mg once nightly 2–3 hours before bedtime is the upper end of the usual RLS dose — at this dose, augmentation monitoring is especially important.
What happens if Pramipex 0.5mg is combined with levodopa?
Pramipexole 0.5mg TID is commonly combined with levodopa in moderate-to-advanced Parkinson's disease. The combination allows reduction of levodopa dose by 20–30%, potentially reducing dyskinesias. The two drugs act synergistically: levodopa provides fast-onset reliable motor control; pramipexole provides smooth background dopaminergic stimulation. When adding pramipexole to established levodopa therapy, start at 0.125mg TID and titrate gradually while reducing levodopa dose as tolerated. Monitor carefully for additive side effects: hallucinations, orthostatic hypotension, dyskinesias, and somnolence.
Is Pramipex 0.5mg safe in elderly patients with Parkinson's disease?
Pramipexole is generally preferred over ergot dopamine agonists in elderly patients but is used with greater caution than levodopa in patients over 70. Orthostatic hypotension is more pronounced in elderly — monitoring (lying and standing) is mandatory. Somnolence and sleep attacks are more common and carry greater fall risk. Hallucinations and confusion are significantly more prevalent in elderly patients at all pramipexole doses — even 0.5mg TID. For elderly patients with Parkinson's disease and cognitive impairment, levodopa monotherapy is generally preferred over dopamine agonists. Use lowest effective dose; consider early switch to levodopa if tolerance issues arise.
Does renal impairment require dose adjustment of Pramipex 0.5mg?
Yes — pramipexole 0.5mg TID exceeds the recommended maximum for patients with moderate renal impairment (eGFR 30–50 mL/min: maximum 1.5mg twice daily, not TID). For patients on 0.5mg TID who develop renal impairment, dose reduction to 0.5mg twice daily or switching to a different Parkinson's medication is needed. Check renal function at baseline, annually, and when symptoms of accumulation appear (increased somnolence, orthostatic hypotension, hallucinations). Pramipexole is not significantly dialysed — dialysis patients require very low doses under specialist supervision.
How does Pramipex 0.5mg compare to cabergoline for Parkinson's disease?
Pramipexole 0.5mg TID (non-ergot dopamine agonist) and cabergoline 1–2mg/day (ergot dopamine agonist) both treat Parkinson's disease by stimulating dopamine receptors. Cabergoline's once-daily dosing is convenient; pramipexole requires three-times-daily dosing (or extended-release once daily). However, ergot dopamine agonists (cabergoline, bromocriptine) carry a serious risk of cardiac valvulopathy (pulmonary and heart valve fibrosis) with long-term use — echocardiographic monitoring is mandatory. Non-ergot pramipexole does not carry this cardiac risk. Most current guidelines prefer non-ergot agonists as first-line agents.
Is Pramipex 0.5mg equivalent to Mirapex 0.5mg?
Yes. Pramipex 0.5mg and branded Mirapex 0.5mg both contain pramipexole dihydrochloride 0.5mg in bioequivalent immediate-release formulations. Pramipex is the generic alternative providing the same Parkinson's disease and RLS treatment quality as branded Mirapex at significantly lower cost.
Can I order Pramipex 0.5mg from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Pramipex 0.5mg to the USA, UK, Australia, and many countries worldwide. Our genuine manufacturer-verified medications, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international source for ongoing pramipexole therapy.
What side effects are most important to monitor at Pramipex 0.5mg?
At 0.5mg TID, impulse control disorder risk becomes clinically significant — directly question patients about gambling, sexual behaviour, spending, and eating compulsions. Somnolence increases with dose — reassess driving safety. Orthostatic hypotension persists — check standing at each visit. Peripheral oedema (ankle swelling) may appear at mid-range doses — compression stockings help. Hallucinations are possible, especially in elderly. Nausea generally resolves by this dose. Any appearance of compulsive behaviour, confusion, or excessive sleepiness warrants dose review before further escalation.
How long should pramipexole 0.5mg TID be maintained before deciding to escalate further?
When motor control is inadequate at 0.5mg TID, wait at least 2–4 weeks at each dose level before escalating further — this allows full pharmacodynamic adaptation and accurate assessment of motor benefit at the current dose. Escalating too quickly overestimates dose requirements and increases side effect burden. If 0.5mg TID provides adequate Parkinson's motor control, maintain this dose and reassess 4–6 monthly. Dose escalation should only occur when clearly inadequate motor control persists despite appropriate patience at the current dose level.
Login
Sign Up
Login
Sign Up